RECKITT BENCKISER GROUP PLC: Completion of Collaboration Agreement 20 May 2013 RECKITT BENCKISER ANNOUNCES COMPLETION OF LATAM OTC COLLABORATION AGREEMENT WITH BRISTOL-MYERS SQUIBB Slough, England - 20 May, 2013 - Reckitt Benckiser Group PLC ("RB") (LSE: RBL) announces that the three year collaboration agreement signed with Bristol-Myers Squibb Company (NYSE: BMY) on 10 February 2013 has been completed and that regulatory approvals, including anti-trust approvals in the relevant jurisdictions, have now been obtained. The terms of the agreement include the transfer of personnel, supply contracts and an option to acquire legal title to the related intellectual property at the end of the collaboration period, based on business performance. Reckitt Benckiser will account for the transaction as a business combination. ENDS Investor & Analyst Contacts: Reckitt Benckiser (RB) Richard Joyce Director, Investor Relations +44 1753 217800 Media Contacts: Reckitt Benckiser (RB) Andraea Dawson-Shepherd SVP, Global Corporate Communication & Affairs +44 1753 446447 Brunswick (Financial PR) David Litterick / Max McGahan +44 (0)20 7404 5959 END -0- May/20/2013 06:00 GMT
RECKITT BENCKISER GROUP PLC: Completion of Collaboration Agreement
Press spacebar to pause and continue. Press esc to stop.